Clinical Trial

Aftificial Inteligence in Assisted Reproductive Techniques to Assess Oocyte Quality and Embryo Ploidy

Study acronym: SMARTAI
Recruiting
View on ClinicalTrials.gov →
Summary
The assisted reproduction success rate is affected by several factors including the age of the women, oocyte quality and maturation state, as well as sperm quality. Imaging of the meiotic spindle may be crucial for determining the oocyte maturation. Artificial intelligence (AI) will be applied to establish the complex oocyte quality, embryo ploidy and pregnancy success probability from the sequence of data, starting with the recording of the meiotic spindle in polarized light, through paternal factors up to the time lapse recording of early embryo development. This strategy should reduce the cost of fertility treatment thanks to increased efficiency in choosing the most promising candidates and reducing the need for costly laboratory analyses.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-01.
Trial Details
NCT Number NCT06539104
Lead Sponsor Charles University, Czech Republic
Collaborators: Czech Academy of Sciences, Czech Technical University in Prague, General University Hospital, Prague
Conditions Infertility, Infertility, Female, Infertility, Male, Infertility Unexplained
Enrollment 1,000 participants
Start Date 2024-01-05
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-22